The Kensington Reston is proud to host “Care. Cure. Prevent.,” a dynamic virtual event dedicated to unraveling the complexities of Alzheimer’s disease, from groundbreaking treatments to preemptive strategies for health maintenance.
We extend a heartfelt invitation for you to engage in this confluence of compassion and hope set to take place on Nov. 15, from 6:00 p.m. to 7:00 p.m. EST.
Heading this illuminating journey is Lauren Miller Rogen, who co-founded Hilarity for Charity (HFC) alongside her husband Seth Rogen, galvanized into action by her mother’s personal battle with the disease.
Lauren shares, “I always look forward to Care. Cure. Prevent. Each year, we hear from incredible experts, answering questions directly from the community about dementia treatment, prevention, and care. I always learn something new and am honored to bring these important discussions to our shared community at HFC, Kensington Senior Living, and beyond.”
This collaborative venture is further enhanced by our expert panel, including:
- Dr. Irina Anna Skylar-Scott is a Board-Certified, Fellowship-TrainedCognitive and Behavioral Neurologist and Clinical Assistant Professor at Stanford University.
- Dr. Travis Urban is a Cognitive Neurologist and the Associate Director of the Ray Dolby Brain Health Center.
- Dr. Doris Molina-Henry is an Assistant Professor of Research in the Department of Neurology at the University of Southern California’s Keck School of Medicine for the Alzheimer’s Therapeutic Research Institute.
- Dr. Sarah Kremen is a behavioral neurologist and the Director of the Neurobehavior Program at the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedar-Sinai Medical Center.
- Dr. Leila Parand is the Assistant Clinical Professor of Neurology at the Mary S. Easton Center for Alzheimer’s Research and Care at the University of California, Los Angeles.
Our promise is to love and care for your family as we do our own.
Lauren Miller Rogen: HFC’s trailblazer in the fight against Alzheimer’s
Meet Lauren Miller Rogen, the heart and soul of Hilarity for Charity (HFC), an organization conceived in the wake of personal tragedy and fueled by the desire for impactful change.
When Alzheimer’s struck her mother at the tender age of 55, Lauren’s world altered, propelling her onto a path of advocacy and innovation.
Together with her husband, actor and comedian Seth Rogen, Lauren co-founded HFC, marrying Alzheimer’s awareness with the unique power of comedy.
By tapping into humor’s broad appeal, they’ve engaged younger generations, raising both funds and awareness in a manner that’s relatable and engaging.
Their star-studded events and compelling initiatives have broken the silence surrounding Alzheimer’s, introducing light and laughter into spaces often dominated by fear and stigma.
Yet, the mission of HFC transcends entertainment— it’s about meaningful change.
Since its inception, the initiative has raised millions for Alzheimer’s care and caregiver support services, research, and prevention, providing grants for in-home care and pushing the boundaries of scientific inquiry.
Under Lauren’s passionate leadership, HFC shines as a beacon for those affected by Alzheimer’s, exemplifying the power of informed action and communal support.
Dive into “Care. Cure. Prevent.”—a closer look at the event
Embark on a journey of discovery and advocacy in the fight against Alzheimer’s with “Care. Cure. Prevent.”
This isn’t just an informational session— it’s an interactive symposium where your participation is key. Held virtually, this inclusive event welcomes individuals worldwide to register and engage in pivotal discussions led by trailblazers in Alzheimer’s care, research, and prevention.
Your involvement is vital—this experience is designed to be a dialogue, not a lecture.
By registering, you’re granted the exclusive opportunity to pose your questions, which may be featured during the live conversation, ensuring a customized, participatory, and deeply informative environment.
What attendees can anticipate:
- Date & time: Mark your calendars for Wednesday, Nov. 15, 2023, from 6 p.m. to 7 p.m. EST.
- How to participate: RSVP and submit your questions on the registration form.
- Engaging panel discussion: Hear directly from distinguished experts, including leading researchers and medical professionals, as they share the latest in Alzheimer’s research, treatment modalities, and prevention strategies.
- Interactive Q&A session: The discussion will be shaped by your pre-submitted questions, focusing on the topics of utmost importance to participants.
- Cutting-edge developments: Learn about recent advancements in Alzheimer’s detection and treatment, including the impact of new medications and ongoing research.
- Navigating Alzheimer’s: Receive practical advice on coping with a diagnosis, understanding the journey ahead, and maintaining a quality life for those affected and their caregivers.
Don’t miss this chance to interact directly with prominent figures in Alzheimer’s research.
Navigating Alzheimer’s disease: from statistics to personal narratives
Consider a reality where memories, the elements that compose our identity, start to fade.
Picture not recalling cherished family stories or the features of dear ones. This is the challenge Alzheimer’s presents to many, a condition where personal identity gradually recedes, prompting individuals and families to adapt to significant change.
Yet, even amidst these warning signs of Alzheimer’s, there is a resilient thread of hope.
The field of Alzheimer’s research is constantly evolving, shining a light of optimism for those wading through these uncertain times.
As we approach the “Care. Cure. Prevent.” event, it’s critical to highlight some groundbreaking strides that participants will delve into:
- Comprehensive lifestyle interventions: Emerging studies emphasize the influential role of holistic lifestyle changes — such as optimized nutrition, consistent physical activity, and mental exercises — in slowing cognitive decline among those at risk.
- Donanemab: Currently in trial by Eli Lilly, this hopeful pharmaceutical intervenes by targeting a specific form of beta-amyloid known as N3pG, with the potential to decelerate cognitive decline.
- Aduhelm: Despite ongoing debates over its efficacy, the FDA’s greenlighting of Aduhelm marked a paradigm shift in Alzheimer’s therapeutics, concentrating on slowing the disease’s trajectory instead of merely symptom management.
- Biomarker breakthroughs: Cutting-edge diagnostic techniques suggest the possibility of early Alzheimer’s detection via blood tests that pinpoint certain biomarkers, a breakthrough with the power to transform care protocols through timely intervention.
- Targeting Amyloid and Tau proteins: The current treatment pipeline is abuzz with medications aimed at reducing amyloid and tau buildups in the brain, potentially slowing Alzheimer’s progression by addressing its fundamental biological drivers.
Join the movement: empower your journey through Alzheimer’s at The Kensington Reston
Are you a caregiver currently navigating Alzheimer’s, dementia, or Parkinson’s with a loved one? You’re not alone.
The Kensington Reston stands with you, offering expert care and deep compassion. When caregiving overwhelms you, we’re your supportive haven.
Enhance your journey by participating in the “Care. Cure. Prevent.” event and RSVP now to unlock valuable insights into Alzheimer’s care and prevention.
Seeking more direct support? Explore our dedicated Memory Care services.
For personal guidance for your loved one, contact The Kensington Reston. Here, you’ll find strength in community.